{'_data': [['Unknown',
            [['GI',
              u'4.0%), abdo min al pain (3.5% vs. 3.3%), diarrhoe a (3.0% vs. 2.7%) Uncom mo n: gastritis (0.9% vs. 0.7%), oesoph a gitis (0.9% vs. 0.9%), dysph a gi a (0.4% vs. 0.2%), duode nitis (0.2% vs. 0.1%), oesoph a g e a l ulcer (0.2% vs. 0.2%) Rare: glossitis (<0.1% vs. 0.1%), oesoph a g e a l stricture (<0.1% vs. 0.0%) Musculoskeletal and connective tissues disorders: Commo n: musc ulosk el e t al pain (2.1% vs. 1.9%) Investigations: Rare: abnor m al liver function tests* * No releva nt incidenc e s from Phase III osteopor osis studies; freque nc y base d on adver s e event/labor a t or y/r e c h allen g e findings in earlier clinical trials. In a one- year, double- blind, multicentr e study comp a ring risedron a t e sodium 5 mg daily (n= 480) and risedron a t e sodium 35 mg weekly (n=4 8 5) in post m e n o p a u s a l wome n with osteopor osis, the overall safety and tolerability profiles were similar. The following additional adver s e experie nc e s consider e d possibly or proba bly drug relat e d by investiga t or s have been report e d (incidenc e grea t e r in risedron a t e 35 mg than in risedron a t e sodiu m 5 mg group): gastroint e s tin al disorder (1.6% vs. 1.0%) and pain (1.2% vs. 0.8%). In a 2- year study in men with osteopor osis, the overall safety and tolera bility were similar betwe e n the treat m e n t and the place bo groups. Adverse experie nc e s were consist e nt with those previously observe d in wome n. Laboratory findings: Early, transie nt, asymp t o m a ti c and mild decre a s e s in seru m calcium and phosph a t e levels have been observe d in some patient s. The following additional adver s e reactions have been report e d during post- marke ting use (frequ e nc y unknown): Eye disorders: iritis, uveitis Muskuloskeletal and connective tissues disorders: Osteon e c ro sis of the jaw Skin and subcutaneous tissue disorders: Hypers e n sitivity and skin reactions, including angioe d e m a , gener alise d rash, and bullous skin reactions, some sever e.']]]],
 '_pages': [4, 5],
 u'_rank': 1,
 u'_type': u'LSFU'}